8 completed, 5 recruiting, 3 unknown, 1 terminated. 4 Phase 2, 3 Not applicable, 2 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 2 |
| Not applicable | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Neoplasia: new trials by email Literature Review of Neoplasia trials Research Report on Neoplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD) REMS - Osteogenesis Imperfecta, Osteoporosis | Not applicable | Recruiting | Meyer Children's Hospital IRCCS | 100 | 2025-12-04 | 2026-02-17 |
| Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent RVP-001 - Central Nervous System (CNS) Lesions, Brain Metastases | Phase 2 | Completed | Reveal Pharmaceuticals Inc. | 18 | 2024-08-15 | 2025-12-26 |
| Genetic Factors and Pheochromocytomas in Neoplasia Type 2 Neoplasia, Pheochromocytoma | Unknown | Assistance Publique Hopitaux De Marseille | 14 | 2022-02-02 | 2023-07-27 | |
| ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling Alectinib, Atezolizumab, Avelumab - Cancer, Tumors | Phase 2 | Recruiting | Ulrik Lassen | 300 | 2020-08-24 | 2025-07-25 |
| Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative Treatment for Cervical Intra-epithelial Neoplasia Gardasill 9™ vaccine - Neoplasia | Phase 3 | Completed | Imperial College London | 1099 | 2019-11-01 | 2026-05-06 |
| A Study of ASN007 in Patients With Advanced Solid Tumors ASN007: ascending doses, ASN007 RD - Cancer, Malignancy | Phase 1 | Completed | Asana BioSciences | 49 | 2018-01-19 | 2020-07-09 |
| The Drug Rediscovery Protocol (DRUP Trial) Panitumumab, Olaparib, Dabrafenib - Cancer, Tumors | Phase 2 | Recruiting | The Netherlands Cancer Institute | 1550 | 2016-08-01 | 2024-01-24 |
| The Suitability of Sniff Dog as a Tool in Screening Tumors Neoplasia | Unknown | Chang-Qing Gao | 4000 | 2014-01-01 | 2024-02-08 | |
| The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients Neoplasia | Recruiting | Chang-Qing Gao | 2000 | 2014-01-01 | 2024-02-08 | |
| Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors nab-paclitaxel - Neuroblastoma, Rhabdomyosarcoma | Phase 1 / Phase 2 | Completed | Celgene | 107 | 2013-12-04 | 2019-12-27 |
| Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial initial fasting, Secondary fasting - Neoplasia, Cancer | Not applicable | Completed | Charite University, Berlin, Germany | 50 | 2013-10-01 | 2016-12-13 |
| Optical Imaging of Head and Neck Cancer High Resolution Microendoscopy (HRME), Proflavine hemisulfate - Squamous Cell Carcinoma, Neoplasia | Not applicable | Terminated | Sharmila Anandasabapathy, MD | 33 | 2011-12-01 | 2018-02-01 |
| Radiofrequency Ablation for the Treatment of Gastric Dysplasia Radiofrequency ablation of dysplastic mucosa (HALO) - Gastric Dysplasia, Neoplasia | Phase 4 | Completed | Hospital Sao Joao | 10 | 2011-01-01 | 2016-02-22 |
| Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD) 1 blood sample, 2 to 3 blood samples (at inclusion, at 3 months and at 6 months in cases of relapse) - Horton's Disease, Infectious Disease | Completed | Centre Hospitalier Universitaire Dijon | 143 | 2009-07-28 | 2019-05-06 | |
| The Radiation Oncology Registry and Biosample Repository Neoplasia | Recruiting | Abramson Cancer Center at Penn Medicine | 8000 | 2008-06-01 | 2026-03-04 | |
| Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy Polyps, Neoplasia | Unknown | Johannes Gutenberg University Mainz | 200 | 2008-02-01 | 2008-11-18 | |
| Cervical Cancer Early Endpoints and Determinants Cervical Cancer, Cervical Intraepithelial | Completed | National Cancer Institute (NCI) | 3013 | 2003-09-12 | 2020-03-13 |
Neoplasms (17) · Breast Neoplasms (2) · Lung Neoplasms (2) · Melanoma (2) · Uterine Cervical Neoplasms (2) · Bone Diseases, Metabolic (1) · Brain Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Central Nervous System Neoplasms (1) · Colonic Neoplasms (1) · Communicable Diseases (1) · Cushing Syndrome (1) · Dermatofibrosarcoma (1) · Dwarfism, Pituitary (1)
Neoplasms by Site (8) · Skin and Connective Tissue Diseases (6) · Neoplasms by Histologic Type (5) · Pathological Conditions, Signs and Symptoms (5) · Skin Diseases (5) · Neoplasms, Germ Cell and Embryonal (4) · Neoplasms, Nerve Tissue (4) · Neuroectodermal Tumors (4) · Neuroendocrine Tumors (4) · Brain Diseases (3) · Central Nervous System Diseases (3) · Neoplasms, Glandular and Epithelial (3) · Nervous System Diseases (3) · Pathologic Processes (3) · Respiratory Tract Diseases (3)
Axitinib (2) · Erlotinib Hydrochloride (2) · HhAntag691 (2) · Trastuzumab (2) · Vemurafenib (2) · alectinib (2) · atezolizumab (2) · cobimetinib (2) · niraparib (2) · pertuzumab (2) · 130-nm albumin-bound paclitaxel (1) · Ado-Trastuzumab Emtansine (1) · Afatinib (1) · Albumin-Bound Paclitaxel (1) · Alpelisib (1)
Chang-Qing Gao (2) · Abramson Cancer Center at Penn Medicine (1) · Asana BioSciences (1) · Assistance Publique Hopitaux De Marseille (1) · Celgene (1) · Centre Hospitalier Universitaire Dijon (1) · Charite University, Berlin, Germany (1) · Hospital Sao Joao (1) · Imperial College London (1) · Johannes Gutenberg University Mainz (1) · Meyer Children's Hospital IRCCS (1) · National Cancer Institute (NCI) (1) · Reveal Pharmaceuticals Inc. (1) · Sharmila Anandasabapathy, MD (1) · The Netherlands Cancer Institute (1)
United States (6) · France (3) · China (2) · Italy (2) · United Kingdom (2) · Canada (1) · Denmark (1) · Finland (1) · Germany (1) · Netherlands (1) · Portugal (1) · Spain (1) · Sweden (1) · Switzerland (1)
Chang-Qing Gao, MD PhD (2) · Andrew Sikora, MD, PhD (1) · E.E. Voest, prof. (1) · Francisco Baldaque-Silva, MD (1) · Ileana Elias, M.D. (1) · Jay Dorsey, MD, PhD (1) · Maria Kyrgiou, MBBS, FRCP (1) · Nicolas Wentzensen, M.D. (1) · Sharmila Anandasabapathy, MD (1)
PMID 29112672, PMID 29462629, PMID 29699509, PMID 31401903, PMID 32554315, PMID 35086719, PMID 35598186, PMID 36814246, PMID 36870947, PMID 37424386, PMID 38630551, PMID 41166720, PMID 41986720
R44CA261240 (1)